Literature DB >> 32794638

Accurate likelihood inference for the volume under the ROC surface.

Erlis Ruli1, Laura Ventura1.   

Abstract

BACKGROUND: With three ordered diagnostic categories, the volume under the receiver operating characteristic (ROC) surface, which is the extension of the area under the ROC curve for binary diagnostic outcomes, is the most commonly used measure for the overall diagnostic accuracy. For a continuous-scale diagnostic test, classical likelihood-based inference about the area under the ROC curve can be inaccurate, in particular when the sample size is small, and higher order inferential procedures have been proposed. AIM: The goal of this paper is to illustrate higher order likelihood procedures for parametric inference in small samples, which provide accurate point estimates and confidence intervals for the volume under the ROC surface.
METHODS: Simulation studies are performed in order to illustrate the accuracy of the proposed methodology, and two applications to real data are discussed.
RESULTS: We show that likelihood modern inference provide refinements to classical inferential results. Furthermore, the freely available R package likelihoodAsy makes now their use almost automatic.
CONCLUSION: Modern likelihood inference based on higher-order asymptotic methods for the area under the ROC surface provide refinements to classical inferential results. A possible limitation of higher-order asymptotic methods for practical use is that their software implementation can be awkward. Nevertheless, use of the freely available R package likelihoodAsy makes such implementation straightforward.
© 2019 Wiley Periodicals, Inc.

Keywords:  AUC; VUS; diagnostic accuracy; higher order likelihood inference; small sample size; stress-strength model

Year:  2019        PMID: 32794638      PMCID: PMC7941487          DOI: 10.1002/cnr2.1206

Source DB:  PubMed          Journal:  Cancer Rep (Hoboken)        ISSN: 2573-8348


  8 in total

Review 1.  The interpretation of diagnostic tests.

Authors:  D E Shapiro
Journal:  Stat Methods Med Res       Date:  1999-06       Impact factor: 3.021

2.  Estimation of the area under the ROC curve.

Authors:  David Faraggi; Benjamin Reiser
Journal:  Stat Med       Date:  2002-10-30       Impact factor: 2.373

3.  Ordered multiple-class ROC analysis with continuous measurements.

Authors:  Christos T Nakas; Constantin T Yiannoutsos
Journal:  Stat Med       Date:  2004-11-30       Impact factor: 2.373

4.  Measuring and estimating diagnostic accuracy when there are three ordinal diagnostic groups.

Authors:  Chengjie Xiong; Gerald van Belle; J Philip Miller; John C Morris
Journal:  Stat Med       Date:  2006-04-15       Impact factor: 2.373

5.  Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds.

Authors:  Eleonora Duregon; Adele Cassenti; Alessandra Pittaro; Laura Ventura; Rebecca Senetta; Roberta Rudà; Paola Cassoni
Journal:  Neuro Oncol       Date:  2015-02-01       Impact factor: 12.300

6.  Accurate likelihood inference for the volume under the ROC surface.

Authors:  Erlis Ruli; Laura Ventura
Journal:  Cancer Rep (Hoboken)       Date:  2019-12-10

7.  Confidence intervals for differences between volumes under receiver operating characteristic surfaces (VUS) and generalized Youden indices (GYIs).

Authors:  Jingjing Yin; Christos T Nakas; Lili Tian; Benjamin Reiser
Journal:  Stat Methods Med Res       Date:  2017-12-12       Impact factor: 3.021

8.  A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.

Authors:  Ambrogio Fassina; Rocco Cappellesso; Francesca Simonato; Maayan Siri; Laura Ventura; Francesca Tosato; Lill-Tove Busund; Maria Rosa Pelizzo; Matteo Fassan
Journal:  Cancer Cytopathol       Date:  2013-12-10       Impact factor: 5.284

  8 in total
  1 in total

1.  Accurate likelihood inference for the volume under the ROC surface.

Authors:  Erlis Ruli; Laura Ventura
Journal:  Cancer Rep (Hoboken)       Date:  2019-12-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.